1-3 of 3
Erol Ayyildiz
Close
Sort by
Journal Articles

Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Autologous, Non-Purged Peripheral Stem Cell Transplantation for High Risk Neuroblastoma Patients

Emel Unal, MD PROF, Nurdan Tacyildiz, MDPROF, Gulsan Yavuz, PROF, MD, Handan Dincaslan, MD, Gulsah Tanyildiz, MD, Erol Ayyildiz, Muhit Ozcan, MD
Journal: Blood
Blood (2014) 124 (21): 5910.
https://doi.org/10.1182/blood.V124.21.5910.5910
Published: 2014
Journal Articles

Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.

Sule Mine Bakanay, MD, Klara Dalva, MD, Berna Elif Koksoy, MD, Erol Ayyildiz, Muhit Ozcan, M.D., Osman Ilhan, MD, Meral Beksac, MD
Journal: Blood
Blood (2012) 120 (21): 3024.
https://doi.org/10.1182/blood.V120.21.3024.3024
Published: 2012
Journal Articles

Allogeneic Hemapoietic Progenitor Cell Collection Using Four Different Cell Separators: A Retrospective Comparative Analysis.

Mutlu Arat, MD, Onder Arslan, MD, Ender A. Soydan, MD, Erol Ayyildiz, BcS, Klara Dalva, MD, Meltem Tol, BcS, Muhit Ozcan, MD, Günhan Gürman, MD, Taner Demirer, MD, Hamdi Akan, MD, Meral Beksac, MD, Osman Ilhan, MD
Journal: Blood
Blood (2004) 104 (11): 5009.
https://doi.org/10.1182/blood.V104.11.5009.5009
Published: 2004